Back
Cleveland-Cliffs Vs. Janux Therapeutics Industry Stock Comparison
Sell
43
CLF
Cleveland-Cliffs
Last Price:
17.29
Seasonality Move:
3.8%
Buy
65
JANX
Janux Therapeutics
Last Price:
53.57
Seasonality Move:
-2.97%
Sell
43
Cleveland-Cliffs (CLF)
is a Sell
Is Cleveland-Cliffs a Buy, Sell or Hold?
- The current Cleveland-Cliffs [CLF] share price is $17.28. The Score for CLF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- CLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $53.50. The Score for JANX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- JANX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLF Stock Price Chart
What is Cleveland-Cliffs's stock price today?
-
The Cleveland-Cliffs share price today is $17.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $53.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing slight buying pressure.
CLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 41.66 | Sell |
| Chaikin Money Flow: | 7990926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.96 - 17.72) | Sell |
| Bollinger Bands (100): | (17.78 - 21.22) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 59.44 | Buy |
| Chaikin Money Flow: | 422273 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.52 - 57.82) | Buy |
| Bollinger Bands (100): | (16.22 - 52.1) | Buy |
CLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.04 | Buy |
| 20-day SMA: | 17.34 | Sell |
| 50-day SMA: | 19.36 | Sell |
| 200-day SMA: | 17.99 | Sell |
| 8-day EMA: | 17.1 | Buy |
| 20-day EMA: | 17.51 | Sell |
| 50-day EMA: | 18.52 | Sell |
| 200-day EMA: | 18.48 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.26 | Buy |
| 20-day SMA: | 50.54 | Buy |
| 50-day SMA: | 47.45 | Buy |
| 200-day SMA: | 21.75 | Buy |
| 8-day EMA: | 48.95 | Buy |
| 20-day EMA: | 49.12 | Buy |
| 50-day EMA: | 45.81 | Buy |
| 200-day EMA: | 28.34 | Buy |
Cleveland-Cliffs Earnings Growth & CLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.29 per share, and an increase next year of $0.76 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.05 per share, an increase this year of $0.10 per share, and a decrease next year of $0.49 per share.
Cleveland-Cliffs Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||